Stratified Use of Genetic Testing in Liver Disease Improves Diagnostic Yield and Clinical Impact
Authors:
- Angelo Corso FainiAFAngelo Corso Faini
- Michele PinonMPMichele Pinon
- Giulia Margherita Brach Del PreverGPGiulia Margherita Brach Del Prever
- Carmelo Maria RomeoCRCarmelo Maria Romeo
- Maria LucaMLMaria Luca
- Fiorenza MioliFMFiorenza Mioli
- Claudia SagliaCSClaudia Saglia
- Caterina ScolariCSCaterina Scolari
- Tullia CarradoriTCTullia Carradori
- Francesca ArrugaFAFrancesca Arruga
- Cristina ChiadòCCCristina Chiadò
- Anna MorgandoAMAnna Morgando
Open Access
- 4 September 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7906
Abstract
Genetic testing plays an important role in the diagnosing of liver diseases, but its diagnostic performance varies across patient populations. By analyzing diagnostic yield across patient subgroups, this study aims at defining age-tailored diagnostic workflows for a more effective integration of genetic testing into clinical practice. We retrospectively analyzed 203 patients (145 children, 58 adults) with acute or subacute liver disorders of suspected genetic origin who underwent next-generation sequencing, categorized them by clinical diagnosis, and evaluated diagnostic yields to develop age-tailored testing workflows. The median age was 8 years; 65.5% were male, 84.7% White, and 27.6% had undergone liver transplantation. Cholestatic liver disorders (30%) and unexplained liver dysfunction (20.2%) were the most common indications for testing. Overall, genetic testing achieved a definitive diagnosis in 35.5% of patients, with a higher yield in children than adults (41.4% vs. 20.7%). Metabolic disorders had the highest diagnostic yield (83.3%), while PFIC/BRIC and Alagille syndrome were the most frequent genetic diagnoses. Age-specific diagnostic workflows retrospectively enriched the overall diagnostic rate by approximately 11% across age and disease categories. These findings demonstrate that tailoring genetic testing strategies to patient age and clinical presentation can improve diagnostic efficiency and support a standardized integration of genetic testing into hepatology practice.Keywords
Funding Information
- Università degli Studi di Torino
This publication has 38 references indexed in Scilit:
- Advancing diagnosis and management of liver disease in adults through exome sequencingEBioMedicine, 2023
- Cholestatic liver diseases of genetic etiology: Advances and controversiesHepatology, 2022
- Genomic medicine for liver diseaseHepatology, 2022
- A novel COLEC10 mutation in a child with 3MC syndromeEuropean Journal of Medical Genetics, 2021
- Diagnostic yield of clinical exome sequencing as a first-tier genetic test for the diagnosis of genetic disorders in pediatric patients: results from a referral center studyHuman Genetics, 2021
- Clinical utility of genomic analysis in adults with idiopathic liver diseaseJournal of Hepatology, 2019
- Progressive Familial Intrahepatic CholestasisClinics in Liver Disease, 2018
- Next generation sequencing in pediatric hepatology and liver transplantationLiver Transplantation, 2018
- VariantValidator: Accurate validation, mapping, and formatting of sequence variation descriptionsHuman Mutation, 2017
- A path to eradication of hepatitis C in low- and middle-income countriesAntiviral Research, 2015